260 related articles for article (PubMed ID: 24942381)
1. The estimated frequency of antiphospholipid antibodies in young adults with cerebrovascular events: a systematic review.
Sciascia S; Sanna G; Khamashta MA; Cuadrado MJ; Erkan D; Andreoli L; Bertolaccini ML;
Ann Rheum Dis; 2015 Nov; 74(11):2028-33. PubMed ID: 24942381
[TBL] [Abstract][Full Text] [Related]
2. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study.
Mustonen P; Lehtonen KV; Javela K; Puurunen M
Lupus; 2014 Dec; 23(14):1468-76. PubMed ID: 25164304
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
[TBL] [Abstract][Full Text] [Related]
4. Autoantibody explosion in antiphospholipid syndrome.
Shoenfeld Y; Twig G; Katz U; Sherer Y
J Autoimmun; 2008; 30(1-2):74-83. PubMed ID: 18171610
[TBL] [Abstract][Full Text] [Related]
5. Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients.
Tarr T; Lakos G; Bhattoa HP; Shoenfeld Y; Szegedi G; Kiss E
Lupus; 2007; 16(1):39-45. PubMed ID: 17283584
[TBL] [Abstract][Full Text] [Related]
6. Do antiphospholipid antibodies increase the long-term risk of thrombotic complications in young patients with a recent TIA or ischemic stroke?
van Goor MP; Alblas CL; Leebeek FW; Koudstaal PJ; Dippel DW
Acta Neurol Scand; 2004 Jun; 109(6):410-5. PubMed ID: 15147465
[TBL] [Abstract][Full Text] [Related]
7. Stroke and antiphospholipid syndrome-antiphospholipid antibodies are a risk factor for an ischemic cerebrovascular event.
Gašperšič N; Zaletel M; Kobal J; Žigon P; Čučnik S; Šemrl SS; Tomšič M; Ambrožič A
Clin Rheumatol; 2019 Feb; 38(2):379-384. PubMed ID: 30088114
[TBL] [Abstract][Full Text] [Related]
8. Interest of IgG and IgM antiprothrombin autoantibodies in the exploration of antiphospholipid syndrome: a 5-year retrospective study.
Bertin D; Beziane A; Resseguier N; Pelissier M; Morange PE; Mege JL; Bardin N
Rheumatology (Oxford); 2020 Jul; 59(7):1539-1544. PubMed ID: 31630203
[TBL] [Abstract][Full Text] [Related]
9. [Antiphospholipid syndrome and stroke].
Kitagawa Y
Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
[TBL] [Abstract][Full Text] [Related]
10. Antiphospholipid antibodies: lessons from the bench.
Koike T; Bohgaki M; Amengual O; Atsumi T
J Autoimmun; 2007; 28(2-3):129-33. PubMed ID: 17383159
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy outcome in patients with antiphospholipid syndrome after cerebral ischaemic events: an observational study.
Fischer-Betz R; Specker C; Brinks R; Schneider M
Lupus; 2012 Oct; 21(11):1183-9. PubMed ID: 22685017
[TBL] [Abstract][Full Text] [Related]
12. Does the anti-prothrombin antibodies measurement provide additional information in patients with thrombosis?
Bardin N; Alessi MC; Dignat-George F; Vague IJ; Sampol J; Harlé JR; Sanmarco M
Immunobiology; 2007; 212(7):557-65. PubMed ID: 17678713
[TBL] [Abstract][Full Text] [Related]
13. Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study.
Urbanus RT; Siegerink B; Roest M; Rosendaal FR; de Groot PG; Algra A
Lancet Neurol; 2009 Nov; 8(11):998-1005. PubMed ID: 19783216
[TBL] [Abstract][Full Text] [Related]
14. Increased risk of vascular complications in Takayasu's arteritis patients with positive lupus anticoagulant.
Jordan NP; Bezanahary H; D'Cruz DP
Scand J Rheumatol; 2015 May; 44(3):211-4. PubMed ID: 25438797
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and Clinical Associations of Antiphospholipid Antibodies in Systemic Sclerosis: New Data From a French Cross-Sectional Study, Systematic Review, and Meta-Analysis.
Sobanski V; Lemaire-Olivier A; Giovannelli J; Dauchet L; Simon M; Lopez B; Yelnik C; Lambert M; Hatron PY; Hachulla E; Dubucquoi S; Launay D
Front Immunol; 2018; 9():2457. PubMed ID: 30464761
[No Abstract] [Full Text] [Related]
16. The estimated prevalence of antiphospholipid antibodies and criteria-antiphospholipid syndrome in subjects with renal thrombotic microangiopathy.
Aluf O; Parente S; Radin M; Campa L; Gazzola V; Olugbogi A; Tesio N; Ugo H; Zanetti E; Zevallos C; Versino E; Lembo D; Roccatello D; Sciascia S
Lupus; 2024 Jan; 33(1):75-82. PubMed ID: 38116607
[TBL] [Abstract][Full Text] [Related]
17. Clinical value of anti-domain I-β2Glycoprotein 1 antibodies in antiphospholipid antibody carriers. A single centre, prospective observational follow-up study.
Tonello M; Mattia E; Del Ross T; Favaro M; Calligaro A; Hoxha A; Bison E; Pengo V; Ruffatti A
Clin Chim Acta; 2018 Oct; 485():74-78. PubMed ID: 29953850
[TBL] [Abstract][Full Text] [Related]
18. Antiphospholipid syndrome: critical analysis of the diagnostic path.
Pengo V; Banzato A; Bison E; Denas G; Padayattil Jose S; Ruffatti A
Lupus; 2010 Apr; 19(4):428-31. PubMed ID: 20353982
[TBL] [Abstract][Full Text] [Related]
19. Antiphospholipid antibodies and cerebral ischemia in young people.
Brey RL; Hart RG; Sherman DG; Tegeler CH
Neurology; 1990 Aug; 40(8):1190-6. PubMed ID: 2116604
[TBL] [Abstract][Full Text] [Related]
20. Antiphospholipid antibodies and thrombosis: association with acquired activated protein C resistance in venous thrombosis and with hyperhomocysteinemia in arterial thrombosis.
Kassis J; Neville C; Rauch J; Busque L; Chang ER; Joseph L; Le Comte M; Subang R; Fortin PR
Thromb Haemost; 2004 Dec; 92(6):1312-9. PubMed ID: 15583739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
